Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VE818 for Environmental Enteropathy in Pregnancy
NCT07134790Phase 2Recruiting
- Sponsor
- Ghent University
- Start
- Jul 2025
- Primary completion
- Jul 2026
- Modality
- Live Biotherapeutic Products
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in environmental enteric dysfunction (EED) comparing Oral vancomycin + VE818, Oral vancomycin + placebo and Observation only arm (3 arms). Primary endpoint: Change in the mean count in the number of 11 selected fecal bacterial pathogen groups at Day 35. Started Jul 2025; status: recruiting.
02
Drugs
VE818
03
Conditions
environmental enteric dysfunction (EED)
Beyond the preview
Go deeper on NCT07134790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07134790.